BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8417818)

  • 1. Neopterin and prognosis in patients with adenocarcinoma of the colon.
    Weiss G; Kronberger P; Conrad F; Bodner E; Wachter H; Reibnegger G
    Cancer Res; 1993 Jan; 53(2):260-5. PubMed ID: 8417818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of interleukin-6 and neopterin in patients with multiple myeloma.
    Reibnegger G; Krainer M; Herold M; Ludwig H; Wachter H; Huber H
    Cancer Res; 1991 Dec; 51(23 Pt 1):6250-3. PubMed ID: 1933885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer.
    Reibnegger G; Hetzel H; Fuchs D; Fuith LC; Hausen A; Werner ER; Wachter H
    Cancer Res; 1987 Sep; 47(18):4977-81. PubMed ID: 3621185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix.
    Reibnegger GJ; Bichler AH; Dapunt O; Fuchs DN; Fuith LC; Hausen A; Hetzel HM; Lutz H; Werner ER; Wachter H
    Cancer Res; 1986 Feb; 46(2):950-5. PubMed ID: 3940654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
    Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
    Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic indicators for stage II (Dukes' stage B) adenocarcinoma of the colon.
    Asaad SM; Jubelirer SJ; Welch CA
    W V Med J; 2005; 101(5):210-3. PubMed ID: 16422269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Did the stage of diagnosis and the surgical management of colonic cancers change over the last ten years? Apropos of 303 patients].
    Sales JP; Parc R
    Ann Chir; 1994; 48(7):591-5. PubMed ID: 7864533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
    Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
    Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
    Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of tumor stage and lymph node status in patients with colorectal adenocarcinoma using probabilistic neural networks and logistic regression.
    Singson RP; Alsabeh R; Geller SA; Marchevsky A
    Mod Pathol; 1999 May; 12(5):479-84. PubMed ID: 10349985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients.
    Chen CN; Cheng YM; Liang JT; Lee PH; Hsieh FJ; Yuan RH; Wang SM; Chang MF; Chang KJ
    Cancer Res; 2000 Jun; 60(11):2892-7. PubMed ID: 10850434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jass' classification revisited.
    Deans GT; Heatley M; Anderson N; Patterson CC; Rowlands BJ; Parks TG; Spence RA
    J Am Coll Surg; 1994 Jul; 179(1):11-7. PubMed ID: 8019715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.